FT Options’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
$938K Buy
+11,581
New +$886K 1.41% 24
2017
Q1
Sell
-47,227
Closed -$3.38M 317
2016
Q4
$3.38M Buy
47,227
+30,806
+188% +$2.29M 3.88% 5
2016
Q3
$1.3M Buy
16,421
+11,531
+236% +$937K 1.03% 26
2016
Q2
$408K Sell
4,890
-22,500
-82% -$2M 0.35% 56
2016
Q1
$2.52M Sell
27,390
-97,843
-78% -$8.82M 2.64% 6
2015
Q4
$12.7M Buy
+125,233
New +$13M 9.35% 1

Other funds holding GILD

FT Options's GILD Position: Q3 2017 in Review

FT Options opened a new position in Gilead Sciences (GILD) in Q3 2017: 11,581 shares worth $938K. The stake represents 1.41% of the portfolio and ranks #24 among its holdings. This is a return to the name: FT Options previously reported a position in GILD as recently as Q4 2016.

FT Options first reported a position in GILD in Q4 2015 and has held it in 6 quarters since. The position peaked at $12.7M in Q4 2015. 1,503 funds tracked by Wall St. Rank hold GILD as of Q3 2017.

  • FT Options held 11,581 shares of Gilead Sciences worth $938K as of Q3 2017.
  • Gilead Sciences was a new FT Options position in Q3 2017.
  • Gilead Sciences made up 1.41% of FT Options's portfolio in Q3 2017, its #24 holding.
  • FT Options first reported a position in Gilead Sciences in Q4 2015 and has held it in 6 quarters since.
  • FT Options's Gilead Sciences position peaked at $12.7M in Q4 2015.
  • 1,503 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2017.

Based on FT Options's 13F filing for Q3 2017, filed 13 Nov 2017.